Page last updated: 2024-10-31

metyrapone and Esophageal Neoplasms

metyrapone has been researched along with Esophageal Neoplasms in 2 studies

Metyrapone: An inhibitor of the enzyme STEROID 11-BETA-MONOOXYGENASE. It is used as a test of the feedback hypothalamic-pituitary mechanism in the diagnosis of CUSHING SYNDROME.
metyrapone : An aromatic ketone that is 3,3-dimethylbutan-2-one in which the methyl groups at positions 1 and 4 are replaced by pyridin-3-yl groups. A steroid 11beta-monooxygenase (EC 1.14.15.4) inhibitor, it is used in the diagnosis of adrenal insufficiency.

Esophageal Neoplasms: Tumors or cancer of the ESOPHAGUS.

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Suda, T1
Tozawa, F1
Dobashi, I1
Horiba, N1
Ohmori, N1
Yamakado, M1
Yamada, M1
Demura, H1
Hirano, T1

Other Studies

2 other studies available for metyrapone and Esophageal Neoplasms

ArticleYear
Corticotropin-releasing hormone, proopiomelanocortin, and glucocorticoid receptor gene expression in adrenocorticotropin-producing tumors in vitro.
    The Journal of clinical investigation, 1993, Volume: 92, Issue:6

    Topics: 8-Bromo Cyclic Adenosine Monophosphate; Adenoma; Adrenocorticotropic Hormone; Adult; Aged; Arginine

1993
[Changes in plasma ACTH activity by oral administration of SU-4485].
    Nihon Naibunpi Gakkai zasshi, 1967, Nov-20, Volume: 43, Issue:8

    Topics: 17-Hydroxycorticosteroids; Adolescent; Adrenocorticotropic Hormone; Adult; Aneurysm; Animals; Circad

1967